{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:24:01Z","timestamp":1791901441846,"version":"4.3.4"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ajo.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T23:50:03Z","timestamp":1383263403000},"page":"287-293.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2b"],"prefix":"10.1016","volume":"157","author":[{"given":"Jenna","family":"Besley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanita","family":"Pappalardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence W.","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2013.10.012_bib1","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0039-6257(05)80054-2","article-title":"Ocular surface squamous neoplasia","volume":"39","author":"Lee","year":"1995","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/IIO.0b013e3181e246e5","article-title":"Ocular surface squamous neoplasia","volume":"50","author":"Kiire","year":"2010","journal-title":"Int Ophthalmol Clin"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0161-6420(97)30287-5","article-title":"Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia","volume":"104","author":"Tabin","year":"1997","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.012_bib4","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.ophtha.2006.09.026","article-title":"Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution","volume":"114","author":"Hirst","year":"2007","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2013.10.012_bib5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9394(14)73021-1","article-title":"Microscopically controlled excision of conjunctival squamous cell carcinoma","volume":"117","author":"Buus","year":"1994","journal-title":"Am J Opthhalmol"},{"issue":"10","key":"10.1016\/j.ajo.2013.10.012_bib6","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.ophtha.2012.04.022","article-title":"Predictors of ocular surface squamous neoplasia recurrence after excisional surgery","volume":"119","author":"Galor","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.012_bib7","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1136\/bjo.2009.160820","article-title":"Topical chemotherapy for ocular surface squamous neoplasia: current status","volume":"94","author":"Sepulveda","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2147\/OPTH.S1606","article-title":"Topical treatment options for\u00a0conjunctival neoplasms","volume":"2","author":"Kim","year":"2008","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2013.10.012_bib9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/ICO.0b013e318243f61f","article-title":"The use of 1% toluidine blue eye drops in the diagnosis of ocular surface squamous neoplasia","volume":"32","author":"Romero","year":"2013","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib10","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ophtha.2011.08.028","article-title":"Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia","volume":"119","author":"Kieval","year":"2012","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2013.10.012_bib11","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","volume":"119","author":"Kim","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2013.10.012_bib12","doi-asserted-by":"crossref","unstructured":"Bahrami B, Greenwell T, Muecke JS. Long-term outcomes after adjunctive topical 5-fluorouracil or mitomycin C for the treatment of surgically excised localised ocular surface squamous neoplasia. Clin Experiment Ophthalmol. 2013 Aug 8. doi: 10.1111\/ceo.12184. [Epub ahead of print].","DOI":"10.1111\/ceo.12184"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/ICO.0b013e3182523f61","article-title":"Interferon for ocular surface squamous neoplasia in 81 cases: outcomes based on the American Joint Committee on Cancer classification","volume":"32","author":"Shields","year":"2013","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2013.10.012_bib14","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.ophtha.2012.03.045","article-title":"Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up","volume":"119","author":"Krilis","year":"2012","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2013.10.012_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/IOP.0b013e3182392f29","article-title":"Refractory squamous cell carcinoma of the conjunctiva treated with subconjunctival ranibizumab (Lucentis): a two-year study","volume":"28","author":"Finger","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ajo.2013.10.012_bib16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1136\/bjo.2010.183244","article-title":"Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study","volume":"95","author":"Parrozzani","year":"2011","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413007083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939413007083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:10:33Z","timestamp":1757596233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939413007083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0002939413007083"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2013.10.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Ocular Surface Squamous Neoplasia Recurrence after Treatment With Topical Mitomycin C and Interferon Alpha-2b","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}